Mexico - Delayed Quote MXN

AbbVie Inc. (ABBV.MX)

3,600.00
0.00
(0.00%)
At close: June 5 at 1:47:45 PM CST

Research Analysis

Revenue vs. Earnings

Revenue 13.34B
Earnings 4.37B

Q2'24

Q3'24

Q4'24

Q1'25

0
5B
10B
15B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 15142526
Avg. Estimate 14.93B15.34B59.87B64.64B
Low Estimate 14.5B15.04B59.27B62.22B
High Estimate 15.18B15.71B60.85B67.18B
Year Ago Sales 14.46B14.46B56.33B59.87B
Sales Growth (year/est) 3.24%6.10%6.27%7.98%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ABBV.MX --------
S&P 500 13.13%2.46%7.55%14.08%

Upgrades & Downgrades

Downgrade Citigroup: Buy to Neutral 5/14/2025
Maintains Guggenheim: Buy to Buy 4/29/2025
Maintains Raymond James: Outperform to Outperform 4/28/2025
Maintains Evercore ISI Group: Outperform to Outperform 4/28/2025
Maintains Morgan Stanley: Overweight to Overweight 4/28/2025
Initiated Cantor Fitzgerald: Overweight 4/22/2025

Related Tickers